178 related articles for article (PubMed ID: 35378133)
21. Expression and mechanism of exosome-mediated A FOXM1 related long noncoding RNA in gastric cancer.
Zhang Y; Chen L; Ye X; Wu Z; Zhang Z; Sun B; Fu H; Fu C; Liang X; Jiang H
J Nanobiotechnology; 2021 May; 19(1):133. PubMed ID: 33971889
[TBL] [Abstract][Full Text] [Related]
22. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
[TBL] [Abstract][Full Text] [Related]
23. Transcriptome analysis identifies TODL as a novel lncRNA associated with proliferation, differentiation, and tumorigenesis in liposarcoma through FOXM1.
Kanojia D; Kirtonia A; Srujana NSV; Jeevanandan SP; Shyamsunder P; Sampath SS; Dakle P; Mayakonda A; Kaur H; Yanyi J; Koeffler HP; Garg M
Pharmacol Res; 2022 Nov; 185():106462. PubMed ID: 36167276
[TBL] [Abstract][Full Text] [Related]
24. Forkhead Box Protein M1 (FOXM1): Prospective Prognostic Biomarker and Therapeutic Targets in Oral Cancer.
Venkidasamy B; Samynathan R; Govidasamy R
Curr Cancer Drug Targets; 2023; 23(11):834-836. PubMed ID: 37259930
[No Abstract] [Full Text] [Related]
25. LINC01426 contributes to clear cell renal cell carcinoma progression by modulating CTBP1/miR-423-5p/FOXM1 axis via interacting with IGF2BP1.
Jiang Y; Zhang H; Li W; Yan Y; Yao X; Gu W
J Cell Physiol; 2021 Jan; 236(1):427-439. PubMed ID: 32583425
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of FoxM1 by MnSOD Overexpression Contributes to Cancer Stem-Like Cell Characteristics in the Lung Cancer H460 Cell Line.
Fu Z; Cao X; Yang Y; Song Z; Zhang J; Wang Z
Technol Cancer Res Treat; 2018 Jan; 17():1533033818789635. PubMed ID: 30111255
[TBL] [Abstract][Full Text] [Related]
27. N
Ren Z; Hu Y; Sun J; Kang Y; Li G; Zhao H
Bioengineered; 2022 Apr; 13(4):7963-7973. PubMed ID: 35356854
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes.
Teh MT; Gemenetzidis E; Chaplin T; Young BD; Philpott MP
Mol Cancer; 2010 Feb; 9():45. PubMed ID: 20187950
[TBL] [Abstract][Full Text] [Related]
29. FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.
Teh MT; Gemenetzidis E; Patel D; Tariq R; Nadir A; Bahta AW; Waseem A; Hutchison IL
PLoS One; 2012; 7(3):e34329. PubMed ID: 22461910
[TBL] [Abstract][Full Text] [Related]
30. Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis.
Mancini M; De Santis S; Monaldi C; Bavaro L; Martelli M; Gugliotta G; Castagnetti F; Rosti G; Santucci MA; Martinelli G; Cavo M; Soverini S
Hematol Oncol; 2020 Apr; 38(2):201-203. PubMed ID: 31990987
[No Abstract] [Full Text] [Related]
31. Homeodomain interacting protein kinase-2 phosphorylates FOXM1 and promotes FOXM1-mediated tumor growth in renal cell carcinoma.
Liu F; Li N; Liu Y; Zhang J; Zhang J; Wang Z
J Cell Biochem; 2019 Jun; 120(6):10391-10401. PubMed ID: 30609136
[TBL] [Abstract][Full Text] [Related]
32. Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma.
Yu M; Tang Z; Meng F; Tai M; Zhang J; Wang R; Liu C; Wu Q
Tumour Biol; 2016 Jan; 37(1):1289-97. PubMed ID: 26289845
[TBL] [Abstract][Full Text] [Related]
33. LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis.
Ma J; Qi G; Li L
Cell Mol Biol Lett; 2020; 25():34. PubMed ID: 32514270
[TBL] [Abstract][Full Text] [Related]
34. The suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNA.
Wang M; Gartel AL
Oncotarget; 2011 Dec; 2(12):1218-26. PubMed ID: 22203467
[TBL] [Abstract][Full Text] [Related]
35. Retinoids induce antagonism between FOXO3A and FOXM1 transcription factors in human oral squamous cell carcinoma (OSCC) cells.
Osei-Sarfo K; Gudas LJ
PLoS One; 2019; 14(4):e0215234. PubMed ID: 30978209
[TBL] [Abstract][Full Text] [Related]
36. Targeting the FOXM1-regulated long noncoding RNA TUG1 in osteosarcoma.
Li Y; Zhang T; Zhang Y; Zhao X; Wang W
Cancer Sci; 2018 Oct; 109(10):3093-3104. PubMed ID: 30099814
[TBL] [Abstract][Full Text] [Related]
37. LncRNA SBF2-AS1 promotes the progression of cervical cancer by regulating miR-361-5p/FOXM1 axis.
Gao F; Feng J; Yao H; Li Y; Xi J; Yang J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):776-782. PubMed ID: 30856345
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA SLC16A1-AS1: its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma.
Feng H; Zhang X; Lai W; Wang J
Cell Cycle; 2020 Jul; 19(13):1641-1653. PubMed ID: 32450050
[TBL] [Abstract][Full Text] [Related]
39. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.
Park YH; Kim SU; Kwon TH; Kim JM; Song IS; Shin HJ; Lee BK; Bang DH; Lee SJ; Lee DS; Chang KT; Kim BY; Yu DY
Oncogene; 2016 Jul; 35(27):3503-13. PubMed ID: 26500057
[TBL] [Abstract][Full Text] [Related]
40. Meningioma achieves malignancy and erastin-induced ferroptosis resistance through FOXM1-AURKA-NRF2 axis.
Ye Y; Xu L; Zhang L; Zhao P; Cai W; Fu G; Wang T; Tao Z; Shi W; Gu W; Hu J; Yuan G; Wei Y; Xu K; Bao Z; Chao H; Liu N; Zhao L; Tu Y; Ji J
Redox Biol; 2024 Jun; 72():103137. PubMed ID: 38642502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
